Mitotic catastrophe constitutes a special case of apoptosis whose suppression entails aneuploidy

Oncogene

Volumn 23, Issue 25, 2004, Pages 4362-4370

  Castedo, Maria ^a   Perfettini, Jean Luc ^a   Roumier, Thomas ^a   Valent, Alexander ^a   Raslova, Hana ^a   Yakushijin, Kenichi ^b   Horne, David ^b   Feunteun, Jean ^a   Lenoir, Gilbert ^a   Medema, René ^c   Vainchenker, William ^a   Kroemer, Guido ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b OREGON STATE UNIVERSITY   (United States)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Aneuploidy; Cancer; Caspases; Chk 2; Programmed cell death

Indexed keywords

CASPASE; CASPASE 2; CASPASE 3; CYTOCHROME C; PROTEIN P53; ANTINEOPLASTIC ANTIBIOTIC; AZEPINE DERIVATIVE; BENZYLOXYCARBONYLVALYL ALANYL ASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLVALYL-ALANYL-ASPARTYL FLUOROMETHYL KETONE; CASP3 PROTEIN, HUMAN; CD4 ANTIGEN; CHECKPOINT KINASE 2; CYSTEINE PROTEINASE INHIBITOR; DEBROMOHYMENIALDISINE; DOXORUBICIN; PEPTIDE CHLOROMETHYL KETONE; PROTEIN SERINE THREONINE KINASE; PYRROLE DERIVATIVE;

ANEUPLOIDY; APOPTOSIS; ARTICLE; CELL CYCLE; CELL DIVISION; CELL FUSION; CHROMATIN CONDENSATION; CHROMOSOME; CONTROLLED STUDY; CYTOPLASM; DNA DAMAGE; ENZYME ACTIVATION; HETEROKARYON; HUMAN; HUMAN CELL; MEMBRANE PERMEABILITY; METAPHASE; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; MITOSIS; MITOSIS INHIBITION; PRIORITY JOURNAL; RNA INTERFERENCE; BIOLOGICAL MODEL; CELL TRANSFORMATION; CENTROSOME; COLON TUMOR; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENVELOPE GENE; ENZYMOLOGY; GENETIC TRANSFECTION; GENETICS; GIANT CELL; HELA CELL; INTRACELLULAR MEMBRANE; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; ULTRASTRUCTURE;

AMINO ACID CHLOROMETHYL KETONES; ANEUPLOIDY; ANTIBIOTICS, ANTINEOPLASTIC; ANTIGENS, CD4; APOPTOSIS; AZEPINES; CASPASE 2; CASPASE 3; CASPASES; CELL DIVISION; CELL FUSION; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CENTROSOME; COLONIC NEOPLASMS; CYSTEINE PROTEINASE INHIBITORS; DNA DAMAGE; DOXORUBICIN; GENES, ENV; GIANT CELLS; HELA CELLS; HUMANS; INTRACELLULAR MEMBRANES; METAPHASE; MITOCHONDRIA; MITOSIS; MODELS, BIOLOGICAL; PROTEIN-SERINE-THREONINE KINASES; PYRROLES; RNA INTERFERENCE; TRANSFECTION;

EID: 3042537050     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207572     Document Type: Article

References (55)

1. Ahn J, Urist M and Prives C. (2003). J. Biol. Chem., 278, 20480-20489.
2. Barrios Sosa AC, Yakushijin K and Horne DA. (2000). J. Org. Chem., 65, 610-611.
3. Brenner C and Kroemer G. (2000). Science, 289, 1150-1151.
4. Bump NJ, Hackett M, Hugunin M, Seshagiri S, Brady K, Chen P, Ferenz C, Franklin S, Ghayur T, Li P, Licari P, Mankovich J, Shi LF, Greenberg AH, Miller LK and Wong WW. (1995). Science, 269, 1885-1888.
5. Burns TF, Fei P, Scata KA, Dicker DT and El-Deiry WS. (2003). Mol. Cell Biol., 23, 5556-5571.
6. Castedo M, Ferri KF, Blanco J, Roumier T, Larochette N, Barretina J, Amendola A, Nardacci R, Metivier D, Este JA, Piacentini M and Kroemer G. (2001). J. Exp. Med., 194, 1097-1110.
7. Castedo M, Perfettini J-L, Roumier T, Yakushijin K, Horne DA, Medema R and Kroemer G. (2004). Oncogene, Advance Online Publication 29 March 2004, doi: 10.1038/sj.onc.1207573.
8. Castedo M, Roumier T, Blanco J, Ferri KF, Barretina J, Andreau K, Perfettini J-L, Armendola A, Nardacci R, LeDuc P, Ingber DE, Este JA, Modjtahedi N, Piacentini M and Kroemer G. (2002). EMBO J., 21, 4070-4080.
9. Chan TA, Hermeking H, Lengauer C, Kinzler KW and Vogelstein B. (1999). Nature, 401, 616-620.
10. Choma D, Daures JP, Quantin X and Pujol JL. (2001). Br. J. Cancer, 85, 14-22.
11. Daugas E, Susin SA, Zamzami N, Ferri K, Irinopoulos T, Larochette N, Prevost MC, Leber B, Andrews D, Penninger J and Kroemer G. (2000). FASEB J., 14, 729-739.
12. DeWitt N and Knight J. (2002). Nature, 416, 354.
13. Ferri KF, Jacotot E, Blanco J, Esté JA, Zamzami A, Susin SA, Brothers G, Reed JC, Penninger JM and Kroemer G. (2000a). J Exp. Med., 192, 1081-1092.
14. Ferri KF, Jacotot E, Geuskens M and Kroemer G. (2000b). Cell Death Differ., 7, 1137-1139.
15. Ferri KF, Jacotot E, LeDuc P, Geuskens M, Ingber DE and Kroemer G. (2000c). Exp. Cell Sci., 261, 119-126.
16. Ferri KF and Kroemer GK. (2001). Nat. Cell Biol., 3, E255-E263.
17. Goldmacher VS, Bartle LM, Skletskaya S, Dionne CA, Kedersha NL, Vater CA, Han JW, Lutz RJ, Watanabe S, McFarland EDC, Kieff ED, Mocarski ES and Chittenden T. (1999). Proc. Natl. Acad. Sci. USA, 96, 12536-12541.
18. Green DR and Kroemer G. (1998). Trends Cell Biol., 8, 267-271.
19. Green DR and Reed JC. (1998). Science, 281, 1309-1312.
20. Guo Y, Srinivasula SM, Druilhe A, Fernandes-Alnemri T and Alnemri ES. (2002). J. Biol. Chem., 277, 13430-13437.
21. Jallepalli PV and Lengaue C. (2001). Nat. Rev. Cancer, 1, 109-117.
22. Kanda T, Sullivan KF and Wahl GM. (1998). Curr. Biol., 8, 377-385.
23. Kerr JFR, Wyllie AH and Currie AR. (1972). Br. J. Cancer, 26, 239-257.
24. Knudson AG. (2001). Nat. Rev. Cancer, 1, 157-162.
25. Kroemer G and Reed JC. (2000). Nat. Med., 6, 513-519.
26. Lassus P, Opitz-Araya X and Lazebnik Y. (2002). Science, 297, 1352-1354.
27. Leist M and Jaattela M. (2001). Nat. Rev. Mol. Cell Biol., 2, 589-598.
28. Lingle WL, Barren SL, Negron VC, D'Assoro AB, Boeneman K, Liu W, Whitehead CM, Reynolds C and Salisbury JL. (2002). Proc. Natl. Acad. Sci. USA, 99, 1978-1983.
29. Lock RB and Stribinskiene L. (1996). Cancer Res., 56, 4006-4012.
30. Lockshin RA and Zakeri Z. (2002). Curr. Opin. Cell Biol., 14, 727-733.
31. Masuda A and Takahashi T. (2002a). Oncogene, 21, 6884-6897.
32. Masuda A and Takahashi T. (2002b). Oncogene, 21, 6884-6897.
33. Mendelsohn AR, Hamer JD, Wang ZB and Brent R. (2002). Proc. Natl. Acad. Sci. USA, 99, 6871-6876.
34. Nabha SM, Mohammad RM, Dandashi MH, Coupaye-Gerard B, Aboukameel A, Pettit GR and Al-Katib AM. (2002). Clin. Cancer Res., 8, 2735-2741.
35. Paroni G, Henderson C, Schneider C and Brancolini C. (2002). J. Biol. Chem., 277, 15147-15161.
36. Penninger JM and Kroemer G. (1998). Adv. Immunol., 68, 51-144.
37. Penninger JM and Kroemer G. (2003). Nat. Cell Biol., 5, 97-99.
38. Raslova H, Roy L, Vourch C, Lecouedic JP, Brison O, Metivier D, Feunteun J, Kroemer G, Debili N and Vainchenker W. (2003). Blood, 101, 541-544.
39. Ravagnan L, Roumier T and Kroemer G. (2002). J. Cell. Physiol., 192, 131-137.
40. Read SH, Baliga BC, Ekert PG, Vaux DL and Kumar S. (2002). J. Cell Biol., 159, 739-745.
41. Robertson JD, Enoksson M, Suomela M, Zhivotovsky B and Orrenius S. (2002). J. Biol. Chem., 277, 29803-29809.
42. Roninson IB, Broude EV and Chang B-D. (2001). Drug Resist. Updates, 4, 303-313.
43. Roschke AV, Stover K, Tonon G, Schaffer AA and Kirsch IR. (2002). Neoplasia, 4, 19-31.
44. Ruth AC and Roninson IB. (2000). Cancer Res., 60, 2576-2578.
45. Shih I-M, Zhou W, Goodman SN, Lengauer CL, Kinzler KW and Vogelstein B. (2001). Cancer Res., 61, 818-822.
46. Slovak ML, Kopecky KJ, Cassileth PA, Harrington DH, Theil KS, Mohamed A, Paietta E, Willman CL, Head DR, Rowe JM, Forman SJ and Appelbaum FR. (2000). Blood, 96, 4075-4083.
47. Takada S, Kelkar A and Theurkauf WE. (2003). Cell, 113, 87-99.
48. Terada N, Hamazaki T, Oka M, Hoki M, Mastalerz DM, Nakano Y, Meyer EM, Morel L, Petersen BE and Scott EW. (2002). Nature, 416, 542-545.
49. Tort F, Hernandez S, Bea S, Martinez A, Estller M, Herman JG, Puig X, Camacho E, Sanchez M, Nayach I, Lopez-Guillermo A, Fernandez PL, Colomer D, Hernandez L and Campo E. (2002). Blood, 100, 4602-4608.
50. Valent A, Bénard J, Clausse B, Barrois M, Valteau-Couanet D, Terrier-Lacombe MJ, Spengler B and Bernheim A. (2001). Am. J. Pathol., 158, 1579-1584.
51. Vieira HL, Belzacq A-S, Haouzi D, Bernassola F, Cohen I, Jacotot E, Ferri KF, Hamel EH, Bartle LM, Melino G, Brenner C, Goldmacher V and Kroemer G. (2001). Oncogene, 20, 4305-4316.
52. Vogelstein B, Lane D and Levine AJ. (2000). Nature, 408, 307-310.
53. Wang X. (2002). Genes Dev., 15, 2922-2933.
54. Wurmser AE and Gage FH. (2002). Nature, 416, 485-487.
55. Zamzami N and Kroemer G. (2003). Curr. Biol., 13, R71-R73.